Amy Summy, Main Marketing and advertising Officer of Labcorp, Named to Forbes’ CMO Upcoming

Labcorp (NYSE: LH), a major worldwide everyday living sciences firm, right now announced that Amy Summy, govt vice president and main internet marketing officer, was recognized on the 2021 Forbes CMO Future listing for her leadership all through the COVID-19 crisis, when also spearheading the rebranding technique that highlighted the energy of Labcorp’s put together diagnostic and drug enhancement firms. Forbes also regarded Amy’s function in launching various merchandise, such as the company’s Pixel by Labcorp™ at-property testing kits.

This push launch attributes multimedia. See the total release here:

Amy Summy, CMO, Labcorp (Photo: Enterprise Wire)

CMO Following characteristics 50 chief internet marketing officers who are redefining the part that internet marketing performs in their industries. Selected by editors and outside professionals, Forbes CMO Subsequent highlights leaders that serve as purpose types in the parts of innovation, technological know-how, creative imagination, and society.

“Earning an impact on health care and people’s life is why I joined Labcorp,” mentioned Summy. “Over 75,000 Labcorp employees have served on the frontlines battling COVID-19, and our leadership in testing and medical trial capabilities has played a central part in the course of this unprecedented time. I am honored to be identified by Forbes and share this accomplishment with our staff for concentrating on bringing the innovation and scientific skills of Labcorp to market place quickly so we can improve well being and enhance life. I look ahead to building on our basis and doing work with our teams to strengthen patient results in cancer, Alzheimer’s and other ailments.”

Summy joined Labcorp soon after serving in advertising and marketing, digital and management roles at Ernst & Young, TE Connectivity and Sapient. She is the co-founder and board member of No Additional Young ones with Most cancers and is a member of the Corporate Council for the Children’s Hospital of Philadelphia. Her groups have played an crucial position in Labcorp’s throughout the world response to COVID-19 and recently released Labcorp’s new model, which exemplifies the job Labcorp plays in guiding wellness, and its dedication to strengthening health and fitness and bettering lives.

The comprehensive listing and profiles of the honorees are accessible at sites/martyswant/2021/02/11/cmo-subsequent-2021-50-ground breaking-entrepreneurs-transforming-business enterprise-in-a-modified-globe/?sh=445ab84a571e.

About Labcorp
Labcorp is a leading world-wide lifestyle sciences corporation that gives essential facts to assistance medical doctors, hospitals, pharmaceutical corporations, researchers, and individuals make crystal clear and self-confident conclusions. By way of our unparalleled diagnostics and drug enhancement capabilities, we present insights and accelerate innovations to increase health and fitness and increase life. With more than 75,000 workers, we serve shoppers in much more than 100 nations. Labcorp (NYSE: LH) reported earnings of $14 billion in FY2020. Study far more about us at or comply with us on LinkedIn and Twitter @Labcorp.

Cautionary Statement Relating to Forward-Seeking Statements
This push release incorporates ahead-on the lookout statements, which includes but not limited to statements with regard to recognition and status of the Firm. Every single of the ahead-hunting statements is subject to alter centered on various essential elements, numerous of which are further than the Company’s manage, together with devoid of limitation, the COVID-19 pandemic and its effects on our business enterprise and monetary situation as perfectly as basic economic, business enterprise, and marketplace situations, aggressive steps and other unforeseen adjustments and typical uncertainties in the market, changes in authorities polices, which include healthcare reform, shopper getting decisions, such as alterations in payer polices or insurance policies, other adverse steps of governmental and third-occasion payers, modifications in screening rules or recommendations, federal, condition, and local governmental responses to the COVID-19 pandemic, the effect of community belief on the Company’s track record, adverse outcomes in materials litigation matters, failure to sustain or build purchaser associations, our skill to build or acquire new products and solutions and adapt to technological variations, failure in details technology, devices or facts stability, the quantity of earnings times in a fiscal period of time, staff prices, and the result of trade level fluctuations, and personnel relations. These factors, in some cases, have influenced and in the future (together with other variables) could have an impact on the Company’s ability to employ the Company’s organization strategy and precise success could vary materially from people recommended by these ahead-looking statements. As a result, readers are cautioned not to position undue reliance on any of our ahead-hunting statements. The Enterprise has no obligation to give any updates to these forward-on the lookout statements even if its expectations adjust. All forward-seeking statements are expressly competent in their entirety by this cautionary statement. Even more facts on possible factors, challenges and uncertainties that could have an impact on operating and money results is incorporated in the Company’s most current Once-a-year Report on Sort 10-K and subsequent Forms 10-Q, including in each case less than the heading Hazard Elements, and in the Company’s other filings with the SEC.


Perspective source model on


Media: Christopher Allman-Bradshaw — 336-436-8263
[email protected]

Investors: Chas Cook — 336-436-5076
[email protected]